SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma

TYPE OF SARCOMA: Metastatic Leiomyosarcoma
DRUG: Mocetinostat & Gemcitabine
ACCRUAL STATUS: Completed

OVERALL STUDY PRINCIPAL INVESTIGATORS:
Shreyas Patel, MD
Co-Principal Investigator
MD Anderson Cancer Center

Edwin Choy, MD, PhD
Co-Principal Investigator
MGH, Dana Farber/Harvard Cancer Center
Division of Hematology Oncology

CLINICALTRIALS.GOV IDENTIFIER: NCT02303262

FOR STUDY DETAILS AND ELIGIBILITY CRITERIA: CLINICALTRIALS.GOV

To learn more about this study or to contact the study research staff: